Skip to main content
Erschienen in: Digestive Diseases and Sciences 9/2016

05.11.2015 | Stanford Multidisciplinary Seminars

Self-Limited Sepsis Syndrome Following Fecal Microbiota Therapy for Refractory C. difficile Infection

verfasst von: Sundeep Singh, Emily Jing, Neil Stollman

Erschienen in: Digestive Diseases and Sciences | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Excerpt

A 56-year-old woman who had denied any prior travel or sick contacts was initially evaluated in the Emergency Department with complaints of 7 days of watery, non-bloody diarrhea, associated with 1 day of nausea and vomiting. She reported having 8–10 bowel movements per day, a frequency that was progressively increasing. One month prior to admission, she had been treated with 10 days of amoxicillin–clavulanate for bacterial sinusitis. Three days prior to admission, she took two doses of loperamide at home without any decrease in the frequency of bowel movements. Ciprofloxacin had been prescribed the day prior to admission without any clinical improvement. She had no significant past medical or surgical history, except for mild depression that was treated with sertraline. …
Literatur
1.
Zurück zum Zitat Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. NEJM. 2015;372:825–834.CrossRefPubMed Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. NEJM. 2015;372:825–834.CrossRefPubMed
2.
Zurück zum Zitat Beran V, Chmelar D, Vobejdova J, et al. Sensitivity to antibiotics of Clostridium difficile toxigenic nosocomial strains. Folia Microbiol. 2014;59:209–215.CrossRef Beran V, Chmelar D, Vobejdova J, et al. Sensitivity to antibiotics of Clostridium difficile toxigenic nosocomial strains. Folia Microbiol. 2014;59:209–215.CrossRef
3.
Zurück zum Zitat Neal MD, Alverdy JC, Hall DE, et al. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe complicated Clostridium difficile associated disease. Ann Surg. 2011;254:423–427.CrossRefPubMed Neal MD, Alverdy JC, Hall DE, et al. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe complicated Clostridium difficile associated disease. Ann Surg. 2011;254:423–427.CrossRefPubMed
4.
Zurück zum Zitat Zainah H, Hassan M, Sheikh-Sroujieh L, et al. Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection. Dig Dis Sci. 2015;60:181–185.CrossRefPubMed Zainah H, Hassan M, Sheikh-Sroujieh L, et al. Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection. Dig Dis Sci. 2015;60:181–185.CrossRefPubMed
5.
Zurück zum Zitat van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. NEJM. 2013;368:407–415.CrossRefPubMed van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. NEJM. 2013;368:407–415.CrossRefPubMed
6.
Zurück zum Zitat Quera R, Espinoza R, Estay C, et al. Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn’s disease and recurrent Clostridium difficile infection. J Crohn’s Colitis. 2014;8:252–253.CrossRef Quera R, Espinoza R, Estay C, et al. Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn’s disease and recurrent Clostridium difficile infection. J Crohn’s Colitis. 2014;8:252–253.CrossRef
7.
Zurück zum Zitat Kelly CR, Ihunnah C, Monika Fischer, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109:1065–1071.CrossRefPubMed Kelly CR, Ihunnah C, Monika Fischer, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109:1065–1071.CrossRefPubMed
Metadaten
Titel
Self-Limited Sepsis Syndrome Following Fecal Microbiota Therapy for Refractory C. difficile Infection
verfasst von
Sundeep Singh
Emily Jing
Neil Stollman
Publikationsdatum
05.11.2015
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 9/2016
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3955-7

Weitere Artikel der Ausgabe 9/2016

Digestive Diseases and Sciences 9/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.